Merck, Pfizer and Syndax Announce Collaboration to Evaluate Combination of Avelumab and Entinostat in Ovarian Cancer
DARMSTADT, Germany & NEW YORK & WALTHAM, Mass.–(BUSINESS WIRE)– Merck, Pfizer and Syndax Pharmaceuticals, Inc. announced today that they have entered into a collaboration agreement...